Skip to content
10-K

Annual Report

Kiniksa Pharmaceuticals International, plc KNSA

0001104659-26-019168

← back to feed
Filed
Feb 24, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 78.98M sh
Shares Diluted FY 2025 · Dec 31, 2024 71.42M sh
Shares Diluted FY 2025 · Dec 31, 2023 71.92M sh
Capex FY 2025 · Dec 31, 2025 $1.57M
Capex FY 2025 · Dec 31, 2024 $277K
Capex FY 2025 · Dec 31, 2023 $130K
Operating Cash Flow FY 2025 · Dec 31, 2025 $137.99M
Operating Cash Flow FY 2025 · Dec 31, 2024 $25.69M
Operating Cash Flow FY 2025 · Dec 31, 2023 $13.3M
Short Term Investments FY 2025 · Dec 31, 2025 $248.48M
Short Term Investments FY 2025 · Dec 31, 2024 $60.05M
Cash And Equivalents FY 2025 · Dec 31, 2025 $165.6M
Cash And Equivalents FY 2025 · Dec 31, 2024 $183.58M
Stockholders Equity FY 2025 · Dec 31, 2025 $567.61M
Stockholders Equity FY 2025 · Dec 31, 2024 $438.44M
Stockholders Equity FY 2025 · Dec 31, 2023 $438.84M
Stockholders Equity FY 2025 · Dec 31, 2022 $396.15M
Current Liabilities FY 2025 · Dec 31, 2025 $139.18M
Current Liabilities FY 2025 · Dec 31, 2024 $100.62M
Total Liabilities FY 2025 · Dec 31, 2025 $196.03M
Total Liabilities FY 2025 · Dec 31, 2024 $142.12M
Current Assets FY 2025 · Dec 31, 2025 $527.18M
Current Assets FY 2025 · Dec 31, 2024 $331.8M
Total Assets FY 2025 · Dec 31, 2025 $763.63M
Total Assets FY 2025 · Dec 31, 2024 $580.55M
Eps Diluted FY 2025 · Dec 31, 2025 $0.75
Eps Diluted FY 2025 · Dec 31, 2024 −$0.60
Eps Diluted FY 2025 · Dec 31, 2023 $0.20
Eps Basic FY 2025 · Dec 31, 2025 $0.80
Eps Basic FY 2025 · Dec 31, 2024 −$0.60
Eps Basic FY 2025 · Dec 31, 2023 $0.20
Sga Expense FY 2025 · Dec 31, 2025 $196.27M
Sga Expense FY 2025 · Dec 31, 2024 $168.01M
Sga Expense FY 2025 · Dec 31, 2023 $129.43M
Rd Expense FY 2025 · Dec 31, 2025 $96.85M
Rd Expense FY 2025 · Dec 31, 2024 $111.62M
Rd Expense FY 2025 · Dec 31, 2023 $76.1M
Net Income FY 2025 · Dec 31, 2025 $59.01M
Net Income FY 2025 · Dec 31, 2024 −$43.19M
Net Income FY 2025 · Dec 31, 2023 $14.08M
Operating Income FY 2025 · Dec 31, 2025 $77.22M
Operating Income FY 2025 · Dec 31, 2024 −$45.62M
Operating Income FY 2025 · Dec 31, 2023 −$25.2M
Cost Of Revenue FY 2025 · Dec 31, 2025 $77.67M
Cost Of Revenue FY 2025 · Dec 31, 2024 $60.91M
Cost Of Revenue FY 2025 · Dec 31, 2023 $33.41M
Revenue FY 2025 · Dec 31, 2025 $677.56M
Revenue FY 2025 · Dec 31, 2024 $423.24M
Revenue FY 2025 · Dec 31, 2023 $270.26M